Exploring a Patient-Centered Methodology to Identify Suitable Proxy Conditions as a Source for Utility Data, Using

Alice M Biggane1, Sofia Schiavo2, Rowena Randall1

  • 1Pfizer Ltd, Walton Oaks, Tadworth, England, UK.

Summary

This study introduces a patient-centered method to select proxy health conditions for estimating health-related quality of life (HRQoL) utility values when direct data is unavailable, using alopecia areata (AA) as an example.